Human Growth Hormone
Sponsors
Royal Marsden NHS Foundation Trust, University of Aarhus, Ascendis Pharma A/S, Center for Human Reproduction, Federico II University
Conditions
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaFemale Infertility Due to Diminished Ovarian ReserveGrowth Hormone DeficiencyGrowth Hormone Deficiency (GHD)HealthyHeart FailureIdiopathic Short Stature
Phase 1
Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)
CompletedNCT01010425
Start: 2009-11-30End: 2010-05-31Updated: 2010-06-08
Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
NCT02179255
Start: 2014-08-01End: 2022-06-30Target: 30Updated: 2020-02-18
Dexamethasone/Pancreatic Clamp P&F
WithdrawnNCT06126354
Start: 2024-07-01End: 2026-03-31Updated: 2024-07-10
Phase 2
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.
CompletedNCT00300664
Start: 2002-07-31End: 2005-04-30Target: 150Updated: 2006-10-13
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
CompletedNCT01947907
Start: 2013-07-31End: 2015-09-30Updated: 2017-01-19
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
RecruitingNCT06382155
Start: 2024-10-21End: 2036-12-01Target: 100Updated: 2026-03-13